Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases
Journal of the American College of Surgeons,

Abbott DE et al. – The simultaneous resection strategy was oncologically equivalent and more cost efficient for patients with primary colorectal cancer presenting with resectable liver metastases. A reduction in overall length of hospital stay was an associated benefit. Future studies should explore the feasibility and clinical implications of policies to maximize the potential for simultaneous resection in this cohort of patients.

Methods
  • Authors conducted a retrospective cohort study of consecutive colorectal cancer patients with resectable synchronous liver metastases treated between 1993 and 2010, constructing a decision tree comparing simultaneous and staged resections.
  • For generalizability, the analysis was conducted from a payer perspective, using costs derived from 2010 Medicare reimbursement.
  • Decision models incorporated the severity–refined DRG complications (complicating condition/major complicating condition) modifiers.
  • Sensitivity analyses used alternative models of DRG reimbursement.

Results
  • There were 144 patients analyzed. Sixty (41.7%) underwent simultaneous resection and 84 (58.3%) underwent staged resection.
  • Median overall survival did not differ between the simultaneous and the staged cohorts (66.3 vs 65.6 months, respectively), nor did the overall complication rate (38.3% vs 40.5%, respectively).
  • Median total length of hospitalization was significantly shorter in the simultaneous cohort (8 vs 14 days; p = 0.001).
  • In the base model, the simultaneous strategy cost less than the staged strategy ($20,983 vs $25,298 per case)—a savings of 17.1%.
  • Sensitivity analyses examining alternative severity–refined DRG reimbursements demonstrated potential cost savings, in all but 1 extreme sensitivity analysis, ranging from 9.8% to 27.3% favoring simultaneous resection.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Gastroenterology Articles

1 Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: A diagnostic meta-analysis Full Text BMC Gastroenterology, July 14, 2014    Free full text    Evidence Based Medicine

2 Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis Clinical Gastroenterology and Hepatology , June 25, 2014    Evidence Based Medicine    Clinical Article

3 The vitamin D status in inflammatory bowel disease PLOS ONE, July 18, 2014    Clinical Article
Exclusive Author Commentary

4 Why, when and how to de-escalate therapy in inflammatory bowel diseases Alimentary Pharmacology and Therapeutics, July 2, 2014    Review Article

5 Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: Double-blind placebo-controlled trial Neurogastroenterology & Motility, February 10, 2014    Clinical Article

6 Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease-The McGill experience Journal of Crohn's and Colitis, July 9, 2014    Clinical Article

7 Daikenchuto, a traditional Japanese herbal medicine, for the maintenance of surgically induced remission in patients with Crohn's disease: a retrospective analysis of 258 patients Surgery Today, July 21, 2014    Clinical Article

8 Serological markers associated with disease behavior and response to anti-TNF therapy in ulcerative colitis Journal of Gastroenterology and Hepatology, July 15, 2014    Clinical Article

9 Effect of a low-flatulogenic diet in patients with flatulence and functional digestive symptoms Neurogastroenterology & Motility, February 25, 2014    Clinical Article
Exclusive Author Commentary

10 Safety of gastrointestinal endoscopic biopsy in patients taking antithrombotics Digestive Endoscopy, May 5, 2014    Clinical Article

11 Smoking behaviour modifies IL23R-Crohn's disease risk in patients with Crohn's disease Journal of Gastroenterology and Hepatology, July 16, 2014    Clinical Article

12 Family history of inflammatory bowel disease among patients with ulcerative colitis: A systematic review and meta-analysis Journal of Crohn's and Colitis, July 7, 2014    Evidence Based Medicine    Review Article

13 A prospective, randomized, controlled, exploratory study of comprehensive dietary advice in ulcerative colitis: impact on disease activity and quality of life European Journal of Gastroenterology & Hepatology, July 10, 2014    Clinical Article

14 Placebo analgesia in patients with functional and organic abdominal pain: a fMRI study in IBS, UC and healthy volunteers Gut, July 8, 2014    Clinical Article

15 Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease Alimentary Pharmacology and Therapeutics, July 3, 2014    Clinical Article

16 Impact of surveillance of hepatitis B and hepatitis C in patients with inflammatory bowel disease under anti-TNF therapies: Multicenter prospective observational study (REPENTINA 3) Journal of Crohn's and Colitis, July 30, 2014    Clinical Article

17 Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis Alimentary Pharmacology and Therapeutics, July 23, 2014    Clinical Article

18 Risk and management of intra-abdominal abscess in Crohn's disease treated with infliximab Digestion, May 2, 2014    Clinical Article

19 Increased risk of venous thromboembolic events with corticosteroid vs biologic therapy for inflammatory bowel disease Clinical Gastroenterology and Hepatology , July 25, 2014    Clinical Article

20 Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease Alimentary Pharmacology and Therapeutics, July 28, 2014    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close